The prevalence of allergies and other chronic diseases is on the rise, with the number of food allergy cases in the U.S. increasing 50% between 2007 and 2021. These allergies can be life-threatening, and understanding their root cause is more important than ever before.
A new study has brought experts closer to doing just that. The findings, published Tuesday, June 24 in the journal Communications Biology, linked the rise of allergies and other chronic conditions such as asthma and eczema to the disappearance of Bifidobacterium from babies’ guts. These bacteria play a crucial role in breaking down breast milk, particularly complex sugars called human milk oligosaccharides (HMOs). A century ago, they were abundant in the microbiomes of breastfed infants, but their prevalence has dwindled among babies in industrialized nations.
Initial results from the My Baby Biome study—a large-scale investigation of infant gut microbiomes in the U.S.—found that roughly 25% of infants lack detectable Bifidobacteria. The researchers suggest this increases their risk of developing noncommunicable diseases.
“It’s in this population where we have low Bifidobacteria or altered Bifidobacteria that we see a very significant increase in risk for non-communicable disease conditions, or atopic disease conditions such as food allergies, eczema, atopic dermatitis and asthma,” said co-author Stephanie Culler, CEO and co-founder of Persephone Biosciences—the San Diego-based biotech company that created the My Baby Biome study.
According to the company, My Baby Biome is one of the largest and most comprehensive investigations of infant guts in the U.S. to date. This longitudinal study aims to monitor the gut microbiomes and health outcomes of hundreds of infants over seven years. The findings published Tuesday come from the study’s first two years, during which researchers collected and analyzed stool samples from 412 infants aged four weeks to 12 weeks who were “representative of U.S. demographic diversity.”
The researchers found that 76% of U.S. infant guts had deficient levels of Bifidobacteria, and 25% had no detectable Bifidobacteria. These bacteria play a critical role in infant health and development, particularly when it comes to protecting babies from chronic illness. Multiple studies suggest Bifidobacterium has been disappearing from infant microbiomes for decades largely due to dietary changes, cesarean sections, antibiotic use, and sanitation. This trend coincides with a rise in noncommunicable diseases, according to the researchers.
The fact that a quarter of the infants showed a total lack of Bifidobacterium may sound staggering, but Jack Gilbert, a professor of pediatrics at the University of California San Diego, was actually surprised by how low that number was. Some previous estimates suggest that 50% to 60% of U.S. infants lack one type of Bifidobacterium called B. longum infantis, he told Gizmodo in an email. This subspecies is known for its ability to digest HMOs.
From the 412 participants, the researchers received 210 follow-up health surveys at two years of age. Among these babies, 30% had an adverse health outcome, with 12.4% reporting allergies, 21.0% reporting eczema or dermatitis, and 3.3% reporting asthma. Statistical analysis revealed that babies with deficient levels or a total lack of Bifidobacteria—who made up 76% of the participants—were at greater risk of developing chronic immune conditions. What’s more, the researchers found thatinfant Bifidobacterium has a protective effect, reducing relative risk in the population.
This isn’t the first study to link deficient infant Bifidobacterium to increased risk of chronic immune conditions, Gilbert said. Previous studies have shown that when these bacteria digest HMOs, they shape gut microbiome dynamics that help train immune system responses, he explained. Additionally, nutrients produced by the breakdown of breast milk sugars support the development of endocrine, neurological, and immunological cells that prevent the immune system from attacking healthy cells, he added.
Investigating the role that infant microbiomes play in the rise of noncommunicable diseases “is central to the health of our population,” Gilbert said.
Culler agrees. Over the next several years of the My Baby Biome study, she and her colleagues will work to understand the health outcomes that arise from Bifidobacteria-deficiencies over time, probing their impact on neurological disorders, obesity, and even diabetes risk. Unlocking the microbial mechanisms behind these conditions could lay the groundwork for better interventions, she said.
Source link
#Study #U.S #Babies #Missing #Key #Gut #Microbe #Fueling #Allergy #Risk
![Kevin Feige Has Finally Admitted ‘Blade’ Probably Isn’t Happening
“There’s only been one Blade. There’s only ever gonna be one Blade.” When Wesley Snipes spoke those lines in 2024’s Deadpool & Wolverine, audiences cackled. Sure, Deadpool and the characters around him love to make self-referential jokes, but something about Snipes—playing Blade for the first time since 2004’s Blade: Trinity—delivering the joke hit extra hard. Comic-book movie lovers know, of course, that Marvel announced a Blade reboot starring Mahershala Ali all the way back in 2019. It’s had a stop-and-start progression since then and slowly became a bit of a punchline, with many fans coming to believe it would never actually happen. It’s not unheard of in Hollywood that a movie gets announced, then never actually goes into production. But it is unusual when a high-profile Marvel project starring a two-time Oscar winner that was trumpeted from the Hall H stage at San Diego Comic-Con gets quietly shoved to the bottom of the TBD list.
However, Marvel hadn’t made any statement putting Blade to rest until very recently, when Happy Sad Confused podcast host Josh Horowitz came right out and asked Marvel head Kevin Feige for an update on the status of Blade. Horowitz shared the clip in an Instagram reel you can watch here, but this is what they said:
“How much time in therapy have you spent talking about Blade?” Horowitz joked to Feige. “This poor project. We just need to get this done, Kevin … We all want it. Mahershala wants it. How are you feeling at this moment?” Feige replied, “I’m feeling very excited that we got Wesley back for a time in Deadpool & Wolverine and like a gigantic loser and a failure that we didn’t get off the ground with Mahershala.” So he doesn’t say there will never, ever be a new Blade film, no matter what Deadpool & Wolverine would have us believe. But it sure sounds like the Mahershala Ali Blade movie is no longer in play.
Horowitz also asked if there’s a chance Secret Wars could be two films (no), if Doomsday is sticking to its release date (yes), and what the MCU will look like after Secret Wars arrives in late 2027. “I look to the comics as I always do in terms of our storytelling,” Feige said, after noting he doesn’t consider Secret Wars to be a reboot. “And after both the Secret Wars, but particularly the [Jonathan] Hickman Secret Wars from 10 years ago, there’s a nice road map to where we can go.” Horowitz also asked if any actors have signed on for X-Men characters that we don’t know about yet, and Feige said, with supreme vagueness, “Not necessarily.” Perhaps we’ll learn more about that when Marvel’s Hall H panel happens this weekend at San Diego Comic-Con. Marvel didn’t hold its traditional Saturday night panel in 2025, so Feige and company have some catching up to do. Want more io9 news? Check out when to expect the latest Marvel, Star Wars, and Star Trek releases, what’s next for the DC Universe on film and TV, and everything you need to know about the future of Doctor Who. #Kevin #Feige #Finally #Admitted #Blade #Isnt #HappeningBlade,Kevin Feige,Marvel Kevin Feige Has Finally Admitted ‘Blade’ Probably Isn’t Happening
“There’s only been one Blade. There’s only ever gonna be one Blade.” When Wesley Snipes spoke those lines in 2024’s Deadpool & Wolverine, audiences cackled. Sure, Deadpool and the characters around him love to make self-referential jokes, but something about Snipes—playing Blade for the first time since 2004’s Blade: Trinity—delivering the joke hit extra hard. Comic-book movie lovers know, of course, that Marvel announced a Blade reboot starring Mahershala Ali all the way back in 2019. It’s had a stop-and-start progression since then and slowly became a bit of a punchline, with many fans coming to believe it would never actually happen. It’s not unheard of in Hollywood that a movie gets announced, then never actually goes into production. But it is unusual when a high-profile Marvel project starring a two-time Oscar winner that was trumpeted from the Hall H stage at San Diego Comic-Con gets quietly shoved to the bottom of the TBD list.
However, Marvel hadn’t made any statement putting Blade to rest until very recently, when Happy Sad Confused podcast host Josh Horowitz came right out and asked Marvel head Kevin Feige for an update on the status of Blade. Horowitz shared the clip in an Instagram reel you can watch here, but this is what they said:
“How much time in therapy have you spent talking about Blade?” Horowitz joked to Feige. “This poor project. We just need to get this done, Kevin … We all want it. Mahershala wants it. How are you feeling at this moment?” Feige replied, “I’m feeling very excited that we got Wesley back for a time in Deadpool & Wolverine and like a gigantic loser and a failure that we didn’t get off the ground with Mahershala.” So he doesn’t say there will never, ever be a new Blade film, no matter what Deadpool & Wolverine would have us believe. But it sure sounds like the Mahershala Ali Blade movie is no longer in play.
Horowitz also asked if there’s a chance Secret Wars could be two films (no), if Doomsday is sticking to its release date (yes), and what the MCU will look like after Secret Wars arrives in late 2027. “I look to the comics as I always do in terms of our storytelling,” Feige said, after noting he doesn’t consider Secret Wars to be a reboot. “And after both the Secret Wars, but particularly the [Jonathan] Hickman Secret Wars from 10 years ago, there’s a nice road map to where we can go.” Horowitz also asked if any actors have signed on for X-Men characters that we don’t know about yet, and Feige said, with supreme vagueness, “Not necessarily.” Perhaps we’ll learn more about that when Marvel’s Hall H panel happens this weekend at San Diego Comic-Con. Marvel didn’t hold its traditional Saturday night panel in 2025, so Feige and company have some catching up to do. Want more io9 news? Check out when to expect the latest Marvel, Star Wars, and Star Trek releases, what’s next for the DC Universe on film and TV, and everything you need to know about the future of Doctor Who. #Kevin #Feige #Finally #Admitted #Blade #Isnt #HappeningBlade,Kevin Feige,Marvel](https://gizmodo.com/app/uploads/2026/07/Blade_DeadpoolWolverine-1280x853.jpg)




Post Comment